EU allows Pfizer/BioNTech COVID-19 vaccine to be stored at higher temperatures

Pfizer and BioNTech announced today that European authorities approved storage of their COVID-19 vaccine at a new temperature.

Based on data showing stability in standard pharmaceutical freezers, the European Medicines Agency (EMA) approved storage of the vaccine at -25°C to -15°C for a total of two weeks. The FDA’s requirements include two-week storage at the same temperatures, with preferred storage set in an ultra-low temperature freezer between -80ºC to -60ºC.

Get the full story at our sister site, Pharmaceutical Processing World.

---

Filed Under: Drug Delivery, Drug Discovery, Drug Discovery and Development, Infectious Disease
Tagged With: BioNTech, coronavirus, covid-19, COVID-19 vaccine, European Medicines Agency, Pfizer
 

---